Soluble complement receptor 1 is increased in patients with leukemia and after administration of granulocyte colony-stimulating factor

Journal of Leukocyte Biology

Volumn 65, Issue 1, 1999, Pages 94-101

  Sadallah, Salima ^b   Lach, Estelle ^c   Schwarz, Sybille ^c   Gratwohl, Alois ^c   Spertini, Olivier ^a   Schifferli, Jürg Alfred ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NONE

Author keywords

Monoclonal antibody 3D9; Plasma; Stem cells

Indexed keywords

COMPLEMENT RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; COMPLEMENT INHIBITION; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032954517     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.1.94     Document Type: Article

References (39)

1. Fearon, D. T. (1980) Identification of the membrane glycoprotein that is the C3h receptor of the human erythrocyte, polymorphonuclear leukocyte. B lymphocyte, and monocyte. J. Exp. Med. 152, 20-30.
2. Fearon, D., Ahearn, J. M. (1989) Complement receptor type 1 (C3b/C4b receptor: CD 35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor: CD21). In Current Topics in Microbiology and Immunology.The Third Component of Complement. (J. D. Lambris, ed.) Berlin: Springer-Verlag. 153, 83-98.
3. Kazatchkine, M. D., Fearon, D. T. (1990) Deficiencies of human complement receptors type 1 (CR1, CP35) and type 2 (CR2, CD21). Immunodef. Rev. 2, 17-41.
4. Wrigh, S. D., Silverstein, S. C. (1982) Tumor promoting phorbol esters stimulate C3b and C3bi rereptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156, 1149-1164.
5. Medof, M. E., Iida, K., Mold, C., Nussenzweig, V. (1982) Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156, 1739-1754.
6. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., Fearon, D. T. (1990) Soluble human coomplement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
7. Danielsson, C., Pascual, M., French, L., Steiger, G., Schifferli, J. A. (1994) Soluble complement receptor type 1 (CR1) is released from leukocytes by surface cleavage. Eur. J. Immunol. 24, 2725-2731.
8. Yoon, S. H., Fearon, D. T. (1985) Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol. 134, 3332-3337.
9. Pascual, M., Duchosal, M. A., Steiger, G., Giostra, E., Pechere, A., Paccaud, J. P., Danielsson, C., Schifferli, J. A. (1993) Circulating soluble CR1 (CD35): serum levels in diseases and evidence for its relrase by human leukocytes. J. Immunol. 151, 1702-1711.
10. Sadallah, S., Giostra, E., Mentha, G., Schifferli, J. A. (1996) Increased levels of soluble complement receptor 1 in serum of patient with liver diseases. Hepatol. 24, 118-122.
11. Lasky, L., A. (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258, 962-969.
12. Adams, D. H., Shaw, S. (1994) Leukocyte-endothelial interaction and regulation of leukocyte migration. Lancet 343, 831-836.
13. Schleiffenbaum, B., Spertini, O., Tedder, T. F. (1992) Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 119, 229-238.
14. Spertini, O., Callegari, P., Cordey, A. S., Hauert, J., Joggi, J., von Fliedner, V., Schapira, M. (1994) High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 84, 1249-1256.
15. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R., Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann. Intern. Med. 103, 620-625.
16. Pascual, M., Lutz, H. U., Steiger, G., Stammler, P., Schifferli, J. A. (1993) Release of vesicles enriched in complement receptor 1 from human erythrocytes. J. Immunol. 151, 397-404.
17. Pascual, M., Steiger, G., Sadallah, S., Paccaud, J. P., Carpentier, J. L., James, R., Schifferli, J. A. (1994) Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J. Exp. Med. 179, 889-899.
18. Sadallah, S., Lach, E., Lutz, H. U., Schwarz, S., Guerre, P. A., Schifferli, J. A. (1997) CR1, CD35 in synovial fluid from patients with inflammatory joint diseases. Arthr. Rheumatol. 40, 520-526.
19. Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 97 (SuppL.), 77-89.
20. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
21. Colello, R. J., Pott, U., Schwab, M. E. (1994) The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway. J. Neurosci. 14, 2594-2605.
22. Wong, W. W., Klickstein, L. B., Smith, J. A., Weis, J. H., Fearon, D. T. (1985) Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4. Proc. Natl. Acad. Sci. USA 22, 7711-7715.
23. Herrin, D. L., Schmidt, G. W. (1988) Rapid, reversible staining of Northern blots prior to hybridization. Biotech. 6, 196-197.
24. Platts-Mills, T. A., Ishizaka, K. (1974) Activation of the alternate pathway of human complements by rabbit cells. J. Immunol. 113, 348-358.
25. Wilson, J. G., Tedder, T. F., Fearon, D. T. (1983) Characterization of human T lymphocytes that express the C3b receptor. J. Immunol. 131, 684-689.
26. Cohen, J. H. M., Aubry, J. P., Kazatchkine, M. D., Banchereau, J., Revillard, J. P. (1989) Human T lymphocytes expressing C3b/C4b complement recptor type one (CR1, CD35) belong to Fc gamma receptor-positive CD4-positive T cells. Cell, Immunol. 121, 383-390.
27. Yaskanin, D. D., Thompson, L. F., Waxman, F. J. (1992) Distribution and quantitative expression of the complement receptor type 1 (CR1) on human peripheral blood T lymphocytes. Cell. Immunol. 142, 159-176.
28. Rodgaard, A., Thomsen, B. S., Bendixen, G., Bendtzen, K. (1995) Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro. Immunol. Res. 14, 69-76.
29. Berger, M., Wetzler, E. M., Wallis, R. S. (1988) Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood. 71, 151-158.
30. Neuman, E., Huleatt, J. W., Jack, R. M. (1990) Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils. J. Immunol. 145, 3325-3332.
31. Griffin, J. D., Spertini, O., Ernst, T. J., Belvin, M. P., Levine, H. B., Kanakura, Y., Tedder, T. F. (1990) Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J. Immunol. 145, 576-584.
32. Limb, G. A., Hamblin, A. S., Wolstencroft, R. A., Dumonde, D. C. (1991) Selective up-regulalion of human granulocyte integrins and complement receptor 1 by cytokines. Immunol. 74, 696-702.
33. Limb, G. A., Hamblin, A. S., Wolstencroft, R. A., Dumonde, D. C. (1992) Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes. Immunol. 77, 88-94.
34. Moore, F. D., Jr., Jack, R. M., Antin, J. H. (1992) Peripheral blood neutrophils in chronically neutropenic patients respond to granulocyte-macrophage colony-stimulating factor with a specific increase in CR1 expression and CR1 transcription. Blood 79, 1667-1671.
35. Jack, R. M., Fearon, D. T. (1988) Selective synthesis of mRNA and proteins by human peripheral blood neutrophils. J. Immunol. 140, 4286-4293.
36. Tedder, T. F., Fearon, D. T., Gartland, G. L. Cooper, M. D. (1983) Expression of C3b receptors on human be cell and myelomonocytic cells but not natural killer cells. J. Immunol. 130, 1668-1673.
37. Hogg, N., Ross, G. D., Jones, D. B., Slusarenko, M., Walport, M. J., Lachmann, P. J. (1984) Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur. J. Immunol. 14, 236-243.
38. Kahn, J., Ingraham, R. H., Shirley, F., Migaki, G. I., Kishimoto, T. K. (1994) Membrane proximal cleavage of L-selectm: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J. Cell. Biol. 125, 461-470.
39. Stoddart, J. H., Jr., Jasuja, R. R., Sikorski, M. A., von Andrian, U. H., Mier, J. W. (1996) Protease-resistant L-selectin mutants. Down-modulation by cross-linking but not cellular activation. J. Immunnl. 157, 5653-5659.